Which has the lower trailing P/E, CAH or EW?

CAH has the lower trailing P/E: CAH trades at 30.46 and EW at 49.59. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CAH or EW?

Over the past five years, CAH grew revenue faster — CAH at a 9.37% CAGR versus EW at 5.75%.

Does CAH or EW pay a bigger dividend?

CAH pays a dividend (0.87% yield), while EW has no payments in the available dividend history.

Is CAH or EW more profitable?

EW runs the higher net margin — CAH at 0.67% versus EW at 15.43%.

How have CAH and EW total returns compared?

Over the past 10 years, CAH delivered 14.67% and EW delivered 8.24% annualized total return. Past performance doesn't predict future results.

Cardinal Health, Inc. (CAH) vs Edwards Lifesciences Corporation (EW)

A side-by-side comparison of Cardinal Health, Inc. and Edwards Lifesciences Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

CAH

Cardinal Health, Inc.

$51.58B

$220.22HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Edwards Lifesciences Corporation

$49.69B

$86.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — CAH vs EW

growth of $100 · dividends reinvested · last 10y

CAH +281.8% (+14.3%/yr)EW +116.4% (+8.0%/yr)CAH compounded faster over this window

CAH EW

CAH vs EW: by the numbers

•CAH is the larger company ($51.58B vs $49.69B market cap).
•CAH trades at the lower trailing earnings multiple (30.46 vs 49.59 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 0.67% net margin).
•CAH grew revenue faster over the past five years (9.37% vs 5.75% CAGR).
•CAH pays a dividend (0.87% yield), while EW has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CAH	EW
P/E ratio	30.46	49.59
Forward P/E	17.56	28.75
P/S ratio	0.20	7.63
P/B ratio	N/A	4.68
EV / EBITDA	15.88	23.80
FCF yield	8.77%	2.89%

Profitability

Metric	CAH	EW
Gross margin	3.84%	77.98%
Operating margin	1.03%	28.09%
Net margin	0.67%	15.43%
ROE	N/A	9.46%
ROIC	13.45%	10.22%

Dividends

Metric	CAH	EW
Dividend yield	0.87%	N/A
Payout ratio	28.33%	N/A

Growth (annualized)

Metric	CAH	EW
Revenue CAGR (5Y)	9.37%	5.75%
EPS CAGR (5Y)	28.32%	6.87%
FCF CAGR (5Y)	17.40%	6.41%
Total return CAGR (5Y)	37.70%	-6.94%

Frequently asked

Which has the lower trailing P/E, CAH or EW?: CAH has the lower trailing P/E: CAH trades at 30.46 and EW at 49.59. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CAH or EW?: Over the past five years, CAH grew revenue faster — CAH at a 9.37% CAGR versus EW at 5.75%.
Does CAH or EW pay a bigger dividend?: CAH pays a dividend (0.87% yield), while EW has no payments in the available dividend history.
Is CAH or EW more profitable?: EW runs the higher net margin — CAH at 0.67% versus EW at 15.43%.
How have CAH and EW total returns compared?: Over the past 10 years, CAH delivered 14.67% and EW delivered 8.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CAH analysis Full EW analysis Interactive comparison tool

Dig into the metrics

Cardinal Health P/E ratio Edwards Lifesciences P/E ratio Cardinal Health dividend yield Cardinal Health ROE Edwards Lifesciences ROE Cardinal Health operating margin Edwards Lifesciences operating margin Cardinal Health revenue growth Edwards Lifesciences revenue growth Cardinal Health free cash flow Edwards Lifesciences free cash flow

Cardinal Health & Edwards Lifesciences appear in these rankings

25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.